vs
Side-by-side financial comparison of GLAUKOS Corp (GKOS) and Yatsen Holding Ltd (YSG). Click either name above to swap in a different company.
Yatsen Holding Ltd is the larger business by last-quarter revenue ($164.2M vs $150.6M, roughly 1.1× GLAUKOS Corp). GLAUKOS Corp runs the higher net margin — 6.2% vs -0.5%, a 6.7% gap on every dollar of revenue. Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 24.5%).
Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.
Yatsen Holding Ltd is a leading China-based beauty and personal care group. It develops and sells cosmetics, skincare products and fragrances under brands including Perfect Diary, Little Ondine and Abby's Choice, with core markets in mainland China, Southeast Asia, targeting Gen Z and young adult consumers.
GKOS vs YSG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $150.6M | $164.2M |
| Net Profit | $9.4M | $-776.5K |
| Gross Margin | 77.9% | 77.8% |
| Operating Margin | 9.0% | -34.0% |
| Net Margin | 6.2% | -0.5% |
| Revenue YoY | 41.2% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $150.6M | — | ||
| Q4 25 | $143.1M | $164.2M | ||
| Q3 25 | $133.5M | $95.1M | ||
| Q2 25 | $124.1M | $110.9M | ||
| Q1 25 | $106.7M | $106.6M | ||
| Q4 24 | $105.5M | $147.0M | ||
| Q3 24 | $96.7M | $102.3M | ||
| Q2 24 | $95.7M | $118.1M |
| Q1 26 | $9.4M | — | ||
| Q4 25 | $-133.7M | $-776.5K | ||
| Q3 25 | $-16.2M | $-17.0M | ||
| Q2 25 | $-19.7M | $-11.9M | ||
| Q1 25 | $-18.1M | $-17.2M | ||
| Q4 24 | $-33.6M | $-67.7M | ||
| Q3 24 | $-21.4M | $-28.2M | ||
| Q2 24 | $-50.5M | $-14.9M |
| Q1 26 | 77.9% | — | ||
| Q4 25 | -1.1% | 77.8% | ||
| Q3 25 | 78.4% | 75.9% | ||
| Q2 25 | 78.3% | 76.7% | ||
| Q1 25 | 77.2% | 77.7% | ||
| Q4 24 | 72.9% | 73.7% | ||
| Q3 24 | 76.6% | 71.4% | ||
| Q2 24 | 76.4% | 74.7% |
| Q1 26 | 9.0% | — | ||
| Q4 25 | -97.7% | -34.0% | ||
| Q3 25 | -12.3% | -20.9% | ||
| Q2 25 | -18.3% | -17.0% | ||
| Q1 25 | -19.4% | -20.4% | ||
| Q4 24 | -27.2% | -50.3% | ||
| Q3 24 | -25.5% | -32.2% | ||
| Q2 24 | -31.3% | -15.7% |
| Q1 26 | 6.2% | — | ||
| Q4 25 | -93.4% | -0.5% | ||
| Q3 25 | -12.2% | -17.9% | ||
| Q2 25 | -15.8% | -10.8% | ||
| Q1 25 | -17.0% | -16.1% | ||
| Q4 24 | -31.8% | -46.1% | ||
| Q3 24 | -22.1% | -27.6% | ||
| Q2 24 | -52.8% | -12.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-2.34 | — | ||
| Q3 25 | $-0.28 | — | ||
| Q2 25 | $-0.34 | — | ||
| Q1 25 | $-0.32 | — | ||
| Q4 24 | $-0.56 | — | ||
| Q3 24 | $-0.39 | — | ||
| Q2 24 | $-1.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $276.7M | $109.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $670.9M | $428.9M |
| Total Assets | $893.3M | $550.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $276.7M | — | ||
| Q4 25 | $90.8M | $109.4M | ||
| Q3 25 | $98.2M | $97.0M | ||
| Q2 25 | $100.8M | $133.1M | ||
| Q1 25 | $114.3M | $92.3M | ||
| Q4 24 | $169.6M | $112.0M | ||
| Q3 24 | $100.1M | $71.7M | ||
| Q2 24 | $68.1M | $109.6M |
| Q1 26 | $670.9M | — | ||
| Q4 25 | $656.2M | $428.9M | ||
| Q3 25 | $769.5M | $423.1M | ||
| Q2 25 | $765.1M | $431.5M | ||
| Q1 25 | $764.0M | $422.2M | ||
| Q4 24 | $766.9M | $418.1M | ||
| Q3 24 | $668.5M | $516.0M | ||
| Q2 24 | $665.2M | $519.4M |
| Q1 26 | $893.3M | — | ||
| Q4 25 | $893.5M | $550.1M | ||
| Q3 25 | $999.4M | $564.8M | ||
| Q2 25 | $987.0M | $564.4M | ||
| Q1 25 | $966.2M | $534.3M | ||
| Q4 24 | $974.8M | $544.0M | ||
| Q3 24 | $926.5M | $635.6M | ||
| Q2 24 | $919.7M | $635.8M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
